v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue $ 838.5 $ 797.4 $ 1,661.9 $ 1,598.8
Total cost of revenue 422.5 439.5 866.1 849.7
Gross profit 416.0 357.9 795.8 749.1
Operating expenses:        
Selling, general and administrative 238.9 231.4 481.0 456.8
Research and development 94.3 100.2 195.6 197.3
Goodwill impairment charge 134.9 0.0 134.9 0.0
Other charges, net 13.2 14.4 39.4 51.3
Total operating expenses 481.3 346.0 850.9 705.4
Operating (loss) income (65.3) 11.9 (55.1) 43.7
Interest and other income (expense), net 24.6 (11.4) 36.3 (18.1)
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries (40.7) 0.5 (18.8) 25.6
Income tax provision (benefit) 14.2 (3.1) 16.7 5.6
Equity in income of unconsolidated investees, net of tax 4.0 0.6 0.3 1.0
Consolidated net (loss) income (50.9) 4.2 (35.2) 21.0
Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries 1.1 (3.4) 2.4 (4.0)
Net (loss) income attributable to Bruker Corporation (52.0) 7.6 (37.6) 25.0
Dividends on Series A Mandatory Convertible Preferred Stock 10.9 0.0 21.8 0.0
Net (loss) income attributable to Bruker Corporation common shareholders $ (62.9) $ 7.6 $ (59.4) $ 25.0
Net (loss) income per common share attributable to Bruker Corporation common shareholders:        
Basic $ (0.41) $ 0.05 $ (0.39) $ 0.16
Diluted $ (0.41) $ 0.05 $ (0.39) $ 0.16
Weighted average common shares outstanding:        
Basic 152.3 151.6 152.2 151.6
Diluted 152.3 151.7 152.2 151.8
Product        
Total revenue $ 663.7 $ 634.7 $ 1,310.1 $ 1,278.0
Total cost of revenue 332.3 346.1 679.9 668.4
Service and other revenue        
Total revenue 174.8 162.7 351.8 320.8
Total cost of revenue $ 90.2 $ 93.4 $ 186.2 $ 181.3